News & Events

Press Releases:

Fist Assist device achieves significant perforator vein dilation for improved endoAVF placement, p-FACT cohort data show

Read More

Fist Assist Devices, LLC Announces Approval of FACT by University of Chicago Medical Center

Read More

Fist Assist Devices, LLC Announces Formation of Global Medical Advisory Board Led by Dialysis Access Center Medical Director Dr. John Ross

Read More

Fist Assist Devices Earns CE Mark for Vein Compression Device

Read More

Fist Assist Devices, LLC Announces Completion of the Non-Significant Risk FACT Trial

Read More

Fist Assist’s FA-1 Compression Device Studied in FACT for Superficial Arm Vein Dilation

Read More

Significant Superficial Arm Vein Dilation Reported with the FA-1 Device

Read More

Fist Assist device for focal arm massage and increased vein circulation gains FDA nod

Read More

Fist Assist Devices Earns CE Mark for Vein Compression Device

Read More

Fist Assist Devices, LLC Announces U.S. Distribution Deal and Sales Launch
AIROS Medical, Inc. Selected for Commercialization Affiliate for July Launch

Read More

Please read about Fist Assist around the web:

“A further interesting technology featured in the CX Innovation Showcase was the Fist Assist device which is a novel, non-invasive, low-cost device developed to assist with fistula dilation, venous pre-surgery preparation and to decrease total catheter contact time and fistula development time. According to presenter Tej Singh (Los Altos Hills, USA), initial patient compliance with the device has been favourable and a large pre-fistula surgery study is planned.”

CX Innovation Showcase
London, April 27th, 2017

Read More

“No patients [of FistAssist] experienced thrombosis or adverse effects. Patient compliance and satisfaction was high. After 1 month, the mean percentage increase in vein diameter in the FA treatment group was significantly larger (p=0.05 than controls in the first 5 mm segment of the fistula. Even more impressive was the early rapid enlargement of forearm fistulas compared to upper arm at all segments (p<.05) at one month. All fistulae treated with FA are still functional with no adverse outcomes..”

Medical Device News Magazine
Florida, June 2017

Read More

Past Events:

Facebook
Twitter
YouTube
LinkedIn
Instagram